Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital Anomalies

T. Miller, David; P Adam, Margaret; Aradhya, Swaroop; G. Biesecker, Leslie; R. Brothman, Arthur; P. Carter, Nigel; M. Church, Deanna; A. Crolla, John; E. Eichler, Evan; J. Epstein, Charles; Andrew Faucett, W.; Feuk, Lars; M. Friedman, Jan; Hamosh, Ada; Jackson, Laird; B. Kaminsky, Erin; Kok, Klaas; D. Krantz, Ian; M. Kuhn, Robert; Lee, Charles; M. Ostell, James; Rosenberg, Carla; W. Scherer, Stephen; B. Spinner, Nancy; J. Stavropoulos, Dimitri; Tepperberg, James; C. Thorland, Erik; Vermeesch, Joris; Waggoner, Darrel; S. Watson, Michael; Lese Martin, Christa; H. Ledbetter, David

doi:10.1016/j.ajhg.2010.04.006

Public

Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital Anomalies

Published in The American Journal of Human Genetics • May 1, 2010

Authors:

David T. Miller

Margaret P Adam

Swaroop Aradhya

Abstract

Chromosomal microarray (CMA) is increasingly utilized for genetic testing of individuals with unexplained developmental delay/intellectual disability (DD/ID), autism spectrum disorders (ASD), or multiple congenital anomalies (MCA). Performing CMA and G-banded karyotyping on every patient substantial...

Subject

Statement (logic)

Test (biology)

Microarray

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!